While the NAT2 isoenzyme has a major role in the metabolism of xenobiotics, including therapeutic drugs and carcinogens, growing evidence supports an additional role for NAT1 in physiological processes (notably folate and methionine metabolism) and cancer cell biology. The gene discussed is NAT2; the disease is cancer.